Habil Khorakiwala
| Personal information | |
|---|---|
| Full name | Habil Khorakiwala |
| Nationality | Indian |
| Born | 1943 India |
| Occupation | Pharmaceutical entrepreneur |
| Known for | Founder and chairman of Wockhardt |
| Organisation | Wockhardt Ltd. |
| Hurun India Rich List 2025 | Rank #225 · ₹13,870 crore |
Habil Khorakiwala is an Indian businessman associated with Wockhardt. According to the M3M Hurun India Rich List 2025 source listing, Habil Khorakiwala was ranked #225 with reported wealth of ₹13,870 crore. This profile summarises the documented business background and continuing relevance of the subject.
Biography
[edit]Habil Khorakiwala is an Indian pharmaceutical entrepreneur and the founder and chairman of Wockhardt. He has been associated with the company's development in pharmaceuticals, biotechnology and healthcare products.
Khorakiwala trained as a chemical engineer and entered business in the pharmaceutical and healthcare sector. He built Wockhardt from a pharmaceutical operation into a diversified healthcare group with manufacturing and research capabilities.
Personal life
[edit]Publicly available biographical information about Habil Khorakiwala is primarily centred on his professional career and business interests. Personal details are included only where they are relevant to understanding his public biography; readers should rely on reputable disclosures for additional private information.
Business career
[edit]Wockhardt has developed pharmaceutical products, biotechnology operations and healthcare-related businesses, with a presence in India and international markets. Khorakiwala's leadership has been linked to the company's expansion and product development.
His career has involved pharmaceutical manufacturing, research, international operations and healthcare entrepreneurship. Wockhardt has also operated in areas including hospital services and biotechnology at different points in its history.
Achievements and influence
[edit]Khorakiwala is regarded as one of the established figures in India's modern pharmaceutical industry. His business career spans the transformation of a family-led enterprise into an international healthcare company.
His position in the 2025 wealth ranking reflects the scale of the business interests associated with him. Wealth rankings can change with market conditions, company valuations and methodology, so the figure should be treated as a dated estimate rather than a permanent measure of personal wealth.
Social Links
[edit]Corporate and investor information should be checked through Wockhardt's official website and disclosures.
Further reading
[edit]References
[edit]- M3M Hurun India Rich List 2025. Official/source resource. Rank, wealth and company information in the 2025 rich list.
- Wockhardt – Official website. Official/source resource. Corporate information and business background.
- M3M Hurun India Rich List 2025 – source listing. Official/source resource. Background on the Hurun India Rich List and wealth-creation research.
